100 related articles for article (PubMed ID: 31799654)
1. Significance of IL28RA in diagnosis of early pancreatic cancer and its regulation to pancreatic cancer cells by JAK/STAT signaling pathway - effects of IL28RA on pancreatic cancer.
Yang L; Wei WC; Meng XN; Gao J; Guo N; Wu FT; Zeng WW
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9863-9870. PubMed ID: 31799654
[TBL] [Abstract][Full Text] [Related]
2. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
3. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
[TBL] [Abstract][Full Text] [Related]
4. MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.
Xie J; Wen JT; Xue XJ; Zhang KP; Wang XZ; Cheng HH
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1914-1921. PubMed ID: 29687843
[TBL] [Abstract][Full Text] [Related]
5. Lowly expressed EGFR-AS1 promotes the progression of preeclampsia by inhibiting the EGFR-JAK/STAT signaling pathway.
Zhao ZM; Jiang J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6190-6197. PubMed ID: 30338781
[TBL] [Abstract][Full Text] [Related]
6. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.
Macha MA; Rachagani S; Gupta S; Pai P; Ponnusamy MP; Batra SK; Jain M
Cancer Lett; 2013 Dec; 341(2):166-77. PubMed ID: 23920124
[TBL] [Abstract][Full Text] [Related]
7. Chaiqin Chengqi decoction inhibits inflammatory mediators and attenuates acute pancreatitis through deactivation of janus kinase/signal transducer and activator of transcription signaling pathway.
Dong J; Chen X; Song Y; Fei X
J Tradit Chin Med; 2019 Apr; 39(2):166-173. PubMed ID: 32186038
[TBL] [Abstract][Full Text] [Related]
8. The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis.
Hu WM; Liu SQ; Zhu KF; Li W; Yang ZJ; Yang Q; Zhu ZC; Chang J
Int Immunopharmacol; 2023 Aug; 121():110505. PubMed ID: 37348233
[TBL] [Abstract][Full Text] [Related]
9. MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway.
Li LX; Lam IH; Liang FF; Yi SP; Ye LF; Wang JT; Guo WW; Xu M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1487-1493. PubMed ID: 30840270
[TBL] [Abstract][Full Text] [Related]
10. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
11. IL28RA inhibits human epidermal keratinocyte proliferation by inhibiting cell cycle progression.
Yin X; Zhang S; Li B; Zhang Y; Zhang X
Mol Biol Rep; 2019 Feb; 46(1):1189-1197. PubMed ID: 30632069
[TBL] [Abstract][Full Text] [Related]
12. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
14. The Role of JAK-STAT Signaling Activation in Hypertrophied Ligamentum Flavum.
Delen E; Doğanlar O; Delen Ö; Doğanlar ZB; Kılınçer C
World Neurosurg; 2020 May; 137():e506-e516. PubMed ID: 32059970
[TBL] [Abstract][Full Text] [Related]
15. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.
Chen P; Huang L; Zhang Y; Qiao M; Yao W; Yuan Y
Int J Mol Med; 2011 May; 27(5):731-8. PubMed ID: 21369693
[TBL] [Abstract][Full Text] [Related]
16. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
17. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
Toyonaga T; Nakano K; Nagano M; Zhao G; Yamaguchi K; Kuroki S; Eguchi T; Chijiiwa K; Tsuneyoshi M; Tanaka M
Cancer Lett; 2003 Nov; 201(1):107-16. PubMed ID: 14580692
[TBL] [Abstract][Full Text] [Related]
18. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
19. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
[TBL] [Abstract][Full Text] [Related]
20. miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer.
Zhang CS; Lin Y; Sun FB; Gao J; Han B; Li SJ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):146-154. PubMed ID: 30657556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
